26 NC Companies to Present at CED Life Science Conference
Twenty-six life science companies from across North Carolina will present their stories at the Council for Entrepreneurial Development’s 27th annual Life Science Conference Feb. 27-28 at the Raleigh Convention Center.
Entrepreneurs from these companies and four more out-of-state companies will pitch their businesses in front of 1,000 attendees including investors and industry executives.
The presenting North Carolina companies, listed alphabetically, include 14 that have received early stage loans or other financial assistance from the North Carolina Biotechnology Center. They are denoted by an asterisk.
* Falcon Therapeutics - Biotech and Pharmaceutical
MVTRAK - Healthcare IT/Digital Health
* Redbud Labs - Diagnostic
* Ribometrix - Biotech and Pharmaceutical
* Celldom - Biotech and Pharmaceutical
Cellective BioTherapy - Biotech and Pharmaceutical
Element Genomics - Diagnostic
EydisBio - Biotech and Pharmaceutical
* Lindy Biosciences - Drug Delivery
Lumedica - Medical Device
* NIRvana Sciences - Diagnostic
Novoclem Therapeutics - Biotech and Pharmaceutical
PhosphoGam - Biotech and Pharmaceutical
Physcient - Medical Device
StrideBio - Biotech and Pharmaceutical
* Kepley BioSystems - MarineBio
* RFPi - Medical Device
Myocardial Solutions - Diagnostic
Applied LifeSciences & Systems - AgBio
Contego Medical - Medical Device
UVision 360 - Medical Device
VitalFlo - Medical Device
Research Triangle Park
* Cell Microsystems - Biotech and Pharmaceutical
* Clinical Sensors - Diagnostic
Dignify Therapeutics - Biotech and Pharmaceutical
* EncepHeal Therapeutics - Biotech and Pharmaceutical
Conference attendees will also have the opportunity for in-person networking with entrepreneurs from the presenting companies and another two dozen exhibiting companies.
Some of the companies will be participating in a parallel conference, the 2018 Coulter Investment Forum, at the same venue. Hosted by the Wallace H. Coulter Foundation and Duke University, the forum will spotlight life science companies with ties to a dozen top-tier universities from across the country.
In all, about 70 companies will be represented at the two conferences. The companies are listed on the CED’s website.
Featured companies chosen to present at the CED conference were selected by a committee composed of local entrepreneurial community members, including angel investors, venture capital firms, community and corporate partners, and Jay Bigelow, CED’s director of entrepreneurship.
“The CED Life Science Conference provides life science entrepreneurs with unparalleled exposure and valuable connections,” Bigelow said. “With a record number of applicants this year, we are able to feature more entrepreneurs on stage, from emerging startups to companies with significant traction. North Carolina remains a top hub for life science innovation, and these entrepreneurs exemplify the opportunity to successfully start, grow and scale a company here.”
Bigelow noted that applicants listed more than 35 separate entrepreneurial support organizations that have assisted them as they build their businesses, including CED and the Biotech Center.
In addition to the selected companies, a handful of growth-stage entrepreneurs will be recognized as “CED Alumni” and use the conference as a platform to publicly release exclusive, newsworthy updates on the main stage.
Registration for the CED Life Science Conference includes access to attend the Coulter Investment Forum’s company presentations. Attendees who register by Feb. 1 will save $75.
The conference is presented in partnership with NCBiotech and the North Carolina Biosciences Organization (NCBIO), the trade association for the state’s life sciences industry.